We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+8%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
AUM
$9.24B
AUM Growth
-$1.25B
Cap. Flow
-$1.2B
Cap. Flow %
-12.98%
Top 10 Hldgs %
20.23%
Holding
1,512
New
702
Increased
135
Reduced
143
Closed
389

Sector Composition

Rank Sector Weight
1 Healthcare 6.29%
2 Consumer Discretionary 4.04%
3 Technology 3.95%
4 Communication Services 3.85%
5 Financials 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
1376
CALL
Sarepta Therapeutics
SRPT
$1.58B
-121,300
Closed -$20.7M
SRPT icon
1377
PUT
Sarepta Therapeutics
SRPT
$1.58B
-121,700
Closed -$20.7M
STEM icon
1378
Stem
STEM
$49.7M
-43,750
Closed -$17.9M
STNE icon
1379
CALL
StoneCo
STNE
$2.76B
-65,000
Closed -$5.46M
STNE icon
1380
PUT
StoneCo
STNE
$2.76B
-65,000
Closed -$5.46M
STTK icon
1381
Shattuck Labs
STTK
$665M
-20,000
Closed -$1.05M
SYF icon
1382
Synchrony
SYF
$25.2B
-9,100
Closed -$316K
SYF icon
1383
PUT
Synchrony
SYF
$25.2B
-35,000
Closed -$1.22M
TALO icon
1384
Talos Energy
TALO
$2.44B
-257,828
Closed -$2.13M
TARS icon
1385
Tarsus Pharmaceuticals
TARS
$2.63B
-20,000
Closed -$827K
TDOC icon
1386
CALL
Teladoc Health
TDOC
$1.23B
-1,500
Closed -$300K
TEAM icon
1387
CALL
Atlassian
TEAM
$27B
-120,000
Closed -$28.1M
TELA icon
1388
TELA Bio
TELA
$32.2M
-10,263
Closed -$154K
TEVA icon
1389
CALL
Teva Pharmaceuticals
TEVA
$40.1B
-8,500
Closed -$82K
TEVA icon
1390
PUT
Teva Pharmaceuticals
TEVA
$40.1B
-11,900
Closed -$115K
TLRY icon
1391
PUT
Tilray
TLRY
$662M
-2,400
Closed -$198K
TMUS icon
1392
CALL
T-Mobile US
TMUS
$190B
-3,800
Closed -$512K
TMUS icon
1393
PUT
T-Mobile US
TMUS
$190B
-22,600
Closed -$3.05M
TREE icon
1394
LendingTree
TREE
$465M
-57,554
Closed -$15.8M
TRGP icon
1395
CALL
Targa Resources
TRGP
$56.5B
-75,000
Closed -$1.98M
TSHA icon
1396
Taysha Gene Therapies
TSHA
$1.63B
-30,000
Closed -$796K
U icon
1397
Unity
U
$14.9B
-50,000
Closed -$6.16M
UBX
1398
DELISTED
Unity Biotechnology
UBX
-16,508
Closed -$865K
UL icon
1399
Unilever
UL
$139B
-8,667
Closed -$589K
UPS icon
1400
United Parcel Service
UPS
$89.8B
-1,200
Closed -$194K

Similar funds

CAAS Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, CAAS Capital Management held 1,512 positions worth $9.24B, down 12% from $10.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

CAAS Capital Management withdrew a net $1.2B in Q1 2021, closing 389 positions and reducing 143 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $178M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, up from 6.2% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, CAAS Capital Management opened a new position in Gaotu Techedu worth $30.1M.

  • CAAS Capital Management's largest Q1 2021 buy was Gaotu Techedu: 888,365 shares worth $30.1M.
  • CAAS Capital Management added most to Vipshop in Q1 2021, an estimated $87.6M increase.
  • CAAS Capital Management's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $120M.
  • CAAS Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $178M.
  • CAAS Capital Management's ten largest holdings make up 20% of its $9.24B portfolio in Q1 2021.
  • CAAS Capital Management opened 702 new positions and closed 389 in Q1 2021.
  • CAAS Capital Management's portfolio value fell 12% quarter-over-quarter to $9.24B.

Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.